The Centers for Medicare & Medicaid Services (CMS) Branded Prescription Drug Fee Program Communication provides historical correspondence between CMS, manufacturers, and states.
Questions regarding the BPD program for Medicaid should be sent to MedicaidBPD@cms.hhs.gov
Disclaimer: Please note that the information provided on this web page does not bind or obligate the Centers for Medicare and Medicaid Services (CMS). The statements included on this web page are intended to provide information on the Medicaid Branded Prescription Drug Fee Program (BPD) and do not in any way revise or modify the requirements set forth in Section 1927 of the Act, the national drug rebate agreement (NDRA), subsequent program releases, or regulations.
Page last updated on September 26, 2022